2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on Advanced RCC: Does Extended Follow-up Continue to Support Pembrolizumab + Axitinib as a SoC for Patients With Previously Untreated Disease?

0 views
July 15, 2020
Comments 0
Login to view comments. Click here to Login